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Lipotoxicity describes the process of cellular dysfunction in response to lipid overload. In this issue of Cell
Metabolism, Michel and colleagues (2011) provide evidence for a role of snoRNAs in palmitate-induced
oxidative stress.Lipids have numerous functions in the
body and as such are indispensable for
life. Besides being the primary energy
fuel for many tissues, lipids are the basic
structural component of cell membranes,
serve as precursors for various bioactive
lipids, and can act as ligands for several
membrane bound and intracellular
receptor systems. In order to furnish
these various pathways, lipids are contin-
uously taken up by cells. However, in
certain situations, uptake of lipids may
exceed the cellular requirement, leading
to ectopic fat storage (Virtue and Vidal-
Puig, 2010). Chronically elevated lipid
uptake has detrimental effects on host
cell functioning and may eventually lead
to cell death. In that respect, excess lipids
and in particular saturated fatty acids are
(lipo)toxic (Unger and Scherer, 2010). Lip-
otoxicity may manifest itself as enhanced
oxidative stress and endoplasmic retic-
ulum (ER) stress and as elevated proin-
flammatory signaling (Hotamisligil, 2010).
Interest in lipotoxicity has grown substan-
tially in recent years as potential key
mechanisms linking obesity with insulin
resistance, inflammation, and other
obesity-related complications (Virtue
and Vidal-Puig, 2010). Despite ample
research, however, there is still no clear
picture on how lipids and specifically
saturated fatty acids perturb cell function.
Although some people favor a role of
diacylglycerol (DAG), ceramides, or other
fatty acid derivatives, the critical molec-
ular intermediates of lipotoxicity remain
to be identified. In this issue ofCell Metab-
olism, Michel and colleagues identify
three conserved small nucleolar RNAs
(snoRNAs) cotranscribed with the rpL13a
gene and demonstrate their involvement
in palmitate-induced oxidative stressand ER stress response (Michel et al.,
2011).
snoRNAs are ubiquitously expressed
noncoding RNAs of about 60–300 nucleo-
tides. They can be classified into two
groups based on four sequence elements
yielding box C/D and box H/ACA
snoRNAs, which are involved in the 20-
O-ribose methylation and pseudouridyla-
tion of ribosomal RNA (rRNA) nucleotides,
respectively (Kiss, 2002; Matera et al.,
2007). More recently, it has become
evident that snoRNAs are involved in
the regulation of alternative splicing and
give rise to small RNA fragments with
microRNA (miRNA)-like activity, so called
sno-miRNAs (Ender et al., 2008; Kishore
et al., 2010). Hence, snoRNAs are
emerging as a new class of RNA species
potentially involved in regulation of gene
expression.
In this paper, Michel et al. (2011) em-
ployed a proven successful method of
promoter trap mutagenesis in Chinese
hamster ovary (CHO) cells to identify the
60S ribosomal protein rpL13a gene as
critical for palmitate-induced cell death.
Via a vast array of carefully conducted
in vitro experiments, the authors attrib-
uted the effect of the promoter trap muta-
tion to disrupted expression of box C/D
snoRNAs U32a, U33, and U35a, which
are located within introns 2, 4, and 6 of
the targeted rpL13a gene. Using CHO
cells and murine myoblasts, they showed
that lipotoxic myristate, palmitate, and
stearate induced rpL13a snoRNAs U32a,
U33, and U35a, while the less lipotoxic
palmitoleate and oleate had no such
effect. Importantly, knockdown of the
three snoRNAs with antisense oligonucle-
otides protected cells against palmitate-
induced reactive oxygen species (ROS)Cell Metaboproduction, ER stress, and subsequent
cell death. This protective effect was
independent of 20-O-ribose methylation
of rRNA targets, which is the primary
function associated with box C/D
snoRNAs. SnoRNAs-deficient cells were
also protected against H2O2-induced
ROS generation, suggesting that rpL13a
snoRNAs are implicated in the general
cellular response to oxidative stress. To
substantiate these in vitro findings, Michel
et al. next showed that lipopolysaccha-
ride injection stimulated expression of
U32a, U33, and U35 in the mouse liver.
Consistent with a role of rpL13a snoRNAs
in inducing oxidative stress, knockdown
of the snoRNAs reduced superoxide,
protein carbonyls, and oxysterols after
lipopolysaccharide injection.
Palmitate induction of rpL13a in total
RNA pools but not of rpL13a messenger
RNA (mRNA) led the authors to suggest
an effect of palmitate at the level of
transcription or pre-mRNA stabilization.
They showed that palmitate specifically
induced snoRNA levels in cytoplasm and
not in nucleoli, suggesting a cytoplasmic
role of theU32a,U33, andU35a snoRNAs.
An important remaining question is how
palmitate increases these snoRNAs
specifically in the cytoplasm (Figure 1).
Perhaps high levels of palmitate influence
the integrity of the nuclear envelope or
regulate specific proteins that mediate
nucleocytoplasmic transport of snoRNAs.
The appeal of the work by Michel and
colleagues is that it for the first time
links snoRNAs, whose existence may
have eluded many researchers active in
the field of lipotoxicity, to palmitate-
induced lipotoxicity and oxidative stress,
adding an entirely new twist to the mech-
anisms underlying lipotoxicity. This worklism 14, July 6, 2011 ª2011 Elsevier Inc. 1
Figure1. ModelDescribing theRoleofsnoRNAs inPalmitate-Induced
Lipotoxic Cell Death
Fatty acids including palmitate can be converted to protective triglycerides
(TG) or lipotoxic intermediates like diacylglycerol (DAG), ceramides, and other
lipid derivatives. Via a lipotoxic signal of unknown identity, excess palmitate
induces accumulation of snoRNAs U32a, U33, and U35a in the cytoplasm.
These snoRNAs promote oxidative stress, endoplasmic reticulum (ER) stress,
and, eventually, cell death. The question marks point to outstanding questions
related to the identification of snoRNAs as critical intermediates in palmitate-
induced lipotoxicity.
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thought (Figure 1). Given their
induction by saturated fatty
acids and their involvement
in palmitate-induced lipoxic-
ity, it is tempting to speculate
about a potential role of
snoRNAs in lipid metabolism.
This notion not only pertains
to the rpL13a snoRNAs but
could be extended to any of
the over 200 snoRNAs identi-
fied in eukaryotes. Conceiv-
ably, snoRNAs may follow in
the footsteps of miRNAs,
several of which have now
been implicated in regulation
of lipid metabolism (Ferna´n-
dez-Hernando et al., 2011).
Interestingly, no evidence
was found that U32a, U33,
and U35 snoRNAs are
processed into miRNAs.
Currently, the challenge
ahead is to identify and char-
acterize the targets and
possible binding partners of
the snoRNAs to gain further
insight into the functional
link between snoRNA and lip-
otoxicity and the possible
connection with lipid metab-
olism. Since monounsatu-rated fatty acids do not induce cytosolic
accumulation of snoRNAs U32a, U33,
and U35, it will be of great interest to
determine whether this is also true for2 Cell Metabolism 14, July 6, 2011 ª2011 Elspolyunsaturated fatty acids and whether
unsaturated fatty acids might induce their
own snoRNA signature. All in all, the
involvement of snoRNAs U32a, U33,evier Inc.and U35a in the lipotoxic
action of palmitate adds a
completely new dimension to
fatty acid signaling and its
downstream effects.REFERENCES
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